8-K filings / November 18, 2026
ACCENDRA HEALTH INC/VA/: A stock exchange listing notice
ACCENDRA HEALTH INC/VA/ filed a current report (Form 8-K) with the SEC on November 18, 2026. It reports a stock exchange listing notice.
AI-written from the facts below
In plain English
On November 16, 2026, the company received a notice from the New York Stock Exchange regarding its stock exchange listing. The notice reports a delisting decision by the exchange, or a step in a hearing on delisting, and cites Section 802.01D.
What each sentence states
“On November 16, 2026, the company received a notice from the New York Stock Exchange regarding its stock exchange listing.”
- Item 3.01 of Form 8-K covers notices about a company's stock exchange listing.
- Item 3.01: the exchange is the New York Stock Exchange.
- Item 3.01: the company received the exchange's notice on November 16, 2026.
“The notice reports a delisting decision by the exchange, or a step in a hearing on delisting, and cites Section 802.01D.”
- Item 3.01: what it reports: a delisting decision by the exchange, or a step in a hearing on delisting.
- Item 3.01: the rule cited is Section 802.01D.
Item 3.01
Stock exchange listing notice
-
Exchange
New York Stock Exchange
From the filing
Source
“On November 16, 2026, Accendra Health, Inc. (the “Company”) received notice (the “Notice”) from the New York Stock Exchange (“NYSE”) Regulation that it has suspended trading of the Company’s common stock and determined to commence proceedings to delist the Company’s common stock from the NYSE.”
Read by code from this sentence of the filing. -
What it says
A decision to delist, or a step in the hearing on it
From the filing
Source
“On November 16, 2026, Accendra Health, Inc. (the “Company”) received notice (the “Notice”) from the New York Stock Exchange (“NYSE”) Regulation that it has suspended trading of the Company’s common stock and determined to commence proceedings to delist the Company’s common stock from the NYSE.”
Read by code from this sentence of the filing. -
Rule cited
Section 802.01D
From the filing
Source
“The NYSE Regulation determined that the Company’s common stock is no longer suitable for listing based on abnormally low selling price levels, pursuant to Section 802.01D of the NYSE Listed Company Manual.”
Read by code from this sentence of the filing. -
Notice date
November 16, 2026
From the filing
Source
“On November 16, 2026, Accendra Health, Inc. (the “Company”) received notice (the “Notice”) from the New York Stock Exchange (“NYSE”) Regulation that it has suspended trading of the Company’s common stock and determined to commence proceedings to delist the Company’s common stock from the NYSE.”
Read by code from this sentence of the filing.
Not investment advice.Read the filing on SEC.gov
Facts read from the filing's own text; a fact the filing does not state clearly is left out. All documents of this filing on SEC.gov.